Compass Therapeutics
CMPX
CMPX
169 hedge funds and large institutions have $881M invested in Compass Therapeutics in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 60 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
36% more funds holding
Funds holding: 124 → 169 (+45)
16.98% less ownership
Funds ownership: 109.23% → 92.26% (-17%)
80% less call options, than puts
Call options by funds: $2K | Put options by funds: $10K
Holders
169
Holding in Top 10
8
Calls
$2K
Puts
$10K
Top Buyers
| 1 | +$16.7M | |
| 2 | +$13.9M | |
| 3 | +$12.9M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$11.7M |
| 5 |
BlackRock
New York
|
+$9.32M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$17.1M | |
| 3 | -$8.23M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.84M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.19M |
